Menu

1 / 2

Fulcrum Therapeutics, Inc. (FULC) Q1 2026 Earnings Call Transcript

Seeking Alpha·SA Transcripts·7 months ago
#NdjZKaCb
#source#chevron#alpha#fulcrum#call
Reading 0:00
15s threshold

Fulcrum Therapeutics, Inc. ( FULC ) Q1 2026 Earnings Call April 27, 2026 8:00 AM EDT

Company Participants

Alexander Sapir - CEO, President & Director

Alan Musso - Chief Financial Officer

Iain Fraser - Senior Vice President of Early Development

Conference Call Participants

Joseph Schwartz - Leerink Partners LLC, Research Division

Anupam Rama - JPMorgan Chase & Co, Research Division

Kristen Kluska - Cantor Fitzgerald & Co., Research Division

Corinne Jenkins - Goldman Sachs Group, Inc., Research Division

James Condulis - Stifel, Nicolaus & Company, Incorporated, Research Division

Matthew Biegler - Oppenheimer & Co. Inc., Research Division

Gregory Renza - Truist Securities, Inc., Research Division

Presentation

Operator

Good morning, and welcome to Fulcrum Therapeutics First Quarter 2026 Financial Results and Business Update Conference Call.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.